Abstract
Purpose
Second malignant neoplasms (SMN) or second cancers may occur in 2–5 % of childhood cancer survivors within 5–25 years after diagnosis and treatment of a bone sarcoma. The most common are leukemia and breast cancer; salivary gland SMN are exceptional. To enhance the literature, we reviewed our patients with bone sarcomas and evaluated the incidence and outcome of salivary gland SMN.
Materials and methods
We retrospectively studied all patients with osteosarcoma and Ewing’s sarcoma treated at the Istituto Ortopedico Rizzoli with chemotherapy from January 1983 to December 2012. There were 883 osteosarcoma and 543 Ewing’s sarcoma patients. We evaluated the date of diagnosis and histology of bone sarcoma, chemotherapy administered, date of diagnosis and histology of SMN, and survival of patients.
Results
The 10-year incidence of SMN was 3.6 %; the most common were breast cancer, leukemia, sarcomas, and salivary gland neoplasms. The incidence of salivary gland SMN was 0.5 %; there were five male and two female patients with a mean age of 19 years (range 13–28 years) who experienced a salivary gland SMN within a mean interval of 79 months (range 51–97 months). The most common salivary gland involved was the parotid followed by the submandibular gland. One of the seven patients with salivary gland SMN died from his SMN.
Conclusions
Treating physicians should be aware of the risk of salivary gland SMN after chemotherapy for bone sarcomas in children and adolescents. Close follow-up of childhood bone sarcoma survivors for SMN is important.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Ries LAG, Eisner MP, Kosary CL, Hankey BF, Miller BA, Clegg L, Mariotto A, Feuer EJ, Edwards BK (2005) SEER cancer statistics review, 1975–2002. National Cancer Institute, Bethesda. http://seer.cancer.gov/csr/1975_2002. Accessed 5 June 2015
Oeffinger KC, Mertens AC, Sklar CA, For the Childhood Cancer Survivor Study et al (2006) Chronic health conditions in adult survivors of childhood cancer. N Engl J Med 355:1572–1582
Hewitt ME, Weiner SL, Simone JV (2003) Childhood cancer survivorship improving care and quality of life. National Cancer Policy Board (US). http://www.nap.edu/openbook.php?record_id=10767. Accessed 5 June 2015
Travis LB (2006) The epidemiology of second primary cancers. Cancer Epidemiol Biomarkers Prev 15:2020–2026
Curtis RE, Freedman DM, Ron E, Ries LAG, Hacker DG, Edwards BK, Tucker MA, Fraumeni JF Jr. (2006) New malignancies among cancer survivors: SEER cancer registries, 1973–2000. National Cancer Institute, NIH Publ. No. 05-5302. Bethesda. http://seer.cancer.gov/archive/publications/mpmono/MPMonograph_complete.pdf. Accessed 5 June 2015
Haupt R, Jankovic M, Hjorth L, Skinner R (2013) Late effects in childhood cancer survivors and survivorship issues. Epidemiol Prev 37:266–273
Kopp LM, Gupta P, Pelayo-Katsanis L, Wittman B, Katsanis E (2012) Late effects in adult survivors of pediatric cancer: a guide for the primary care physician. Am J Med 125:636–641
Longhi A, Ferrari S, Tamburini A et al (2012) Late effects of chemotherapy and radiotherapy in osteosarcoma and ewing sarcoma patients: the Italian sarcoma group experience (1983–2006). Cancer 118:5050–5059
Bacci G, Forni C, Longhi A et al (2004) Long-term outcome for patients with non-metastatic Ewing’s sarcoma treated with adjuvant and neoadjuvant chemotherapies. 402 patients treated at Rizzoli between 1972 and 1992. Eur J Cancer 40:73–83
Mavrogenis AF, Papagelopoulos PJ, Romantini M, Angelini A, Ruggieri P (2010) Side effects of chemotherapy in musculoskeletal oncology. J Long Term Eff Med Implants 20:1–12
Ozger H, Bulbul M, Eralp L (2010) Complications of limb salvage surgery in childhood tumors and recommended solutions. Strateg Trauma Limb Reconstr 5:11–15
Hundsdoerfer P, Albrecht M, Ruhl U, Fengler R, Kulozik AE, Henze G (2009) Long-term outcome after polychemotherapy and intensive local radiation therapy of high-grade osteosarcoma. Eur J Cancer 45:2447–2451
Bernstein M, Kovar H, Paulussen M, Randall RL, Schuck A, Teot LA, Juergens H (2006) Ewing’s sarcoma family of tumors: current management. Oncologist 11:503–519
Kaste SC, Hedlund G, Pratt CB (1994) Malignant parotid tumors in patients previously treated for childhood cancer: clinical and imaging findings in eight cases. AJR Am J Roentgenol 162:655–659
Boukheris H, Curtis RE, Land CE, Dores GM (2009) Incidence of carcinoma of the major salivary glands according to the WHO classification, 1992 to 2006: a population-based study in the United States. Cancer Epidemiol Biomark Prev 18:2899–2906
Licitra L, Grandi C, Prott FJ, Schornagel JH, Bruzzi P, Molinari R (2003) Major and minor salivary glands tumours. Crit Rev Oncol Hematol 45:215–225
Horn-Ross PL, Morrow M, Ljung BM (1997) Diet and the risk of salivary gland cancer. Am J Epidemiol 146:171–176
Horn-Ross PL, Morrow M, Ljung BM (1999) Menstrual and reproductive factors for salivary gland cancer risk in women. Epidemiology 10:528–530
Cheuk DK, Shek TW, Chan GC et al (2008) Parotid acinar cell carcinoma in a long-term survivor of childhood acute lymphoblastic leukemia. Pediatr Blood Cancer 50:636–639
Whatley WS, Thompson JW, Rao B (2006) Salivary gland tumors in survivors of childhood cancer. Otolaryngol Head Neck Surg 134:385–388
Savelli SL, Klopfenstein KJ, Termuhlen AM (2005) Mucoepidermoid carcinoma of the parotid gland as a second malignant neoplasm. Pediatr Blood Cancer 45:997–1000
Prasannan L, Pu A, Hoff P, Weatherly R, Castle V (1999) Parotid carcinoma as a second malignancy after treatment of childhood acute lymphoblastic leukemia. J Pediatr Hematol Oncol 21:535–538
Rutigliano DN, Meyers P, Ghossein RA et al (2007) Mucoepidermoid carcinoma as a secondary malignancy in pediatric sarcoma. J Pediatr Surg 42:E9–E13
McIntyre JF, Smith-Sorensen B, Friend SH et al (1994) Germline mutations of the p53 tumor suppressor gene in children with osteosarcoma. J Clin Oncol 12:925–930
Chen AM, Garcia J, Granchi PJ, Johnson J, Eisele DW (2008) Late recurrence from salivary gland cancer: when does “cure” mean cure? Cancer 112:340–344
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Funding
None.
Conflict of interest
All authors declare that they have no conflict of interest.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed consent
Informed consent was obtained from all individual participants included in the study.
Rights and permissions
About this article
Cite this article
Longhi, A., Errani, C., Gambarotti, M. et al. Salivary gland second cancer after bone sarcoma treatment. Eur J Orthop Surg Traumatol 25, 1201–1204 (2015). https://doi.org/10.1007/s00590-015-1662-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00590-015-1662-x